Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Longqing Pian is a traditional Chinese medicine (TCM) tablet formulation officially recognized in the Chinese Pharmacopoeia. It is primarily indicated for the treatment of genitourinary disorders characterized by "damp-heat" in TCM theory, such as chronic prostatitis, cystitis, and urinary tract infections. The formulation is a complex botanical mixture containing ingredients like *Herba Patriniae*, *Radix Scutellariae*, and *Flos Lonicerae*. It is recognized for its anti-inflammatory, antibacterial, and analgesic properties, working to alleviate symptoms like urinary frequency, urgency, and pelvic pain. It is manufactured by companies such as Tianjin Zhongxin Pharmaceutical Group.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Longqing Pian.